Risk stratification using sarcopenia status among subjects with metabolic dysfunction‐associated fatty liver disease

BACKGROUND: Sarcopenia is a significant indicator of the severity of non‐alcoholic fatty liver disease. We investigated whether sarcopenia could identify subgroups with different risk of liver fibrosis and atherosclerotic cardiovascular disease (ASCVD) among subjects with metabolic dysfunction‐assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chun, Ho Soo, Kim, Mi Na, Lee, Jae Seung, Lee, Hye Won, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Kim, Seung Up
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517359/
https://www.ncbi.nlm.nih.gov/pubmed/34337887
http://dx.doi.org/10.1002/jcsm.12754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517359/
https://www.ncbi.nlm.nih.gov/pubmed/34337887
http://dx.doi.org/10.1002/jcsm.12754

Ejemplares similares